AJ

Arpit Jain

Active Director Director DIN 10298776
DIN 10298776 First appointment Aug 2023 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Arpit Jain

Data last updated:

Arpit Jain is a Director at Madsmed Pharmaceuticals Private Limited (since 2023). The company operates in Manufacturing. Madsmed Pharmaceuticals Private Limited reported revenue of ₹5.2 Lakh (FY 2019).

DIN 10298776
Primary Designation Director
Industry Manufacturing
First Appointment 29 Aug 2023
Oldest Company Age 8 yrs
Largest company Madsmed Pharmaceuticals Private Limited · ₹5.2 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20232018₹5.2 Lakh (FY 2019)Active

Board colleagues of Arpit Jain

NameDINCompanyDesignation
Aman Trivedi10298788Madsmed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madsmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arpit Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Jain

Arpit Jain currently holds 1 directorship: Madsmed Pharmaceuticals Private Limited (Director, since 29 Aug 2023, revenue ₹5.2 Lakh (FY 2019)).

Arpit Jain was first appointed on 29 Aug 2023 as Director at Madsmed Pharmaceuticals Private Limited.

The current boards of Arpit Jain's companies include Aman Trivedi (Madsmed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available